Oncology & Cancer

Benefit of PET or PET/CT in oesophageal cancer is not proven

The patient-relevant benefit of positron emission tomography (PET) in oesophageal cancer, alone or in combination with computed tomography (CT), is not proven due to a lack of comparative studies. In terms of their diagnostic ...

Oncology & Cancer

Benefit of PET or PET/CT in recurrent bowel cancer is not proven

For patients in whom a recurrence of bowel cancer is suspected, the study data currently available allow no robust conclusions as to the advantages and disadvantages of using positron emission tomography (PET), alone or in ...

Oncology & Cancer

Benefit of PET and PET/CT in ovarian cancer is not proven

Due to the lack of studies, there is currently no proof that patients with ovarian cancer can benefit from positron emission tomography (PET) alone or in combination with computed tomography (CT). As regards diagnostic accuracy, ...

page 2 from 2